Stock Price
12.58
Daily Change
0.19 1.53%
Monthly
-12.58%
Yearly
-70.33%
Q3 Forecast
12.48

Tandem Diabetes Care reported 2.65K in Employees for its fiscal year ending in December of 2024.



Financials
Assets USD 875.74M
Cost of Sales USD 114.82M
Current Assets USD 614.82M
Debt USD 449.01M
EBIT USD -31.86M
EBITDA USD -1.85M
Employees 2.65K
Interest Income USD 4.19M
Loan Capital USD 309.15M
Net Income USD -52.4M
Operating Expenses USD 272.54M
Operating Profit USD -31.86M
Pre-Tax Profit USD -57.72M
Sales Revenues USD 240.68M
Stock USD 142.57M
Trade Creditors USD 55.84M
Trade Debtors USD 128.44M

Employees Change Date
Abbott 114K 1000 Dec/2023
Align Technology 20.94K 665 Dec/2024
AtriCure 1.3K 100 Dec/2024
Baxter International 38K 22K Dec/2024
Becton, Dickinson and Co. 74K 1000 Sep/2024
Boston Scientific 53K 5K Dec/2024
Cooper Companies 16K 1000 Oct/2024
Dexcom 10.3K 700 Dec/2024
Edwards Lifesciences 15.8K 4K Dec/2024
Eli Lilly 47K 4K Dec/2024
Globus Medical 5.3K 300 Dec/2024
ICU Medical 15K 1000 Dec/2024
Insulet 3.9K 900 Dec/2024
Integra LifeSciences 4.4K 450 Dec/2024
J&J 138.1K 6.2K Dec/2024
Masimo 3.6K 200 Dec/2024
Medtronic 95K 0 Apr/2024
Merit Medical Systems 7.4K 450 Dec/2024
Roche Holding 103.61K 2.69K Dec/2022
Stryker 53K 1000 Dec/2024
Tandem Diabetes Care 2.65K 250 Dec/2024
Teleflex 14.1K 400 Dec/2024
Zimmer Biomet Holdings 17K 1000 Dec/2024